Results 221 to 230 of about 114,871 (347)

Robust Four-Field and Arc LET-Optimized Proton Prostate Cancer Treatment Plans With Urethral Sparing. [PDF]

open access: yesInt J Part Ther
Vieceli M   +6 more
europepmc   +1 more source

Prostate Cancer

open access: yesCambridge International Law Journal, 2018
M. Hallek
semanticscholar   +1 more source

The pelvic floor dysfunction: Where obstetrics meets urogynecology

open access: yes
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Ingrid Volloyhaug   +2 more
wiley   +1 more source

Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy

open access: yesBJU International, EarlyView.
Objectives To evaluate the impact of the presence, extent and location of positive surgical margins (PSMs) on the risk of biochemical recurrence (BCR) and metastases in a nationwide cohort of patients who underwent radical prostatectomy (RP) and had 5 years of follow‐up.
Joost van Drumpt   +10 more
wiley   +1 more source

Focal therapy using a novel cooled laser device for prostate cancer: early trial results

open access: yesBJU International, EarlyView.
Objectives To determine the short‐term oncological results and safety of the ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT‐PC) trial, the first phase II clinical trial of ProFocal® (Medlogical Innovations, Sydney, Australia), a novel, cooled laser focal therapy (cLFT) device for prostate cancer (PCa) treatment. Patients and Methods Men with
Jonathan Kam   +17 more
wiley   +1 more source

Out with the old, in with the new? A retrospective comparison of malleable erectile implants in phalloplasty

open access: yesBJU International, EarlyView.
Objective To compare the long‐term outcomes of the two main types of malleable erectile implants after phalloplasty in transgender men: models originally designed for cisgender men (conventional models) or the more recently developed Zephyr Surgical Implants (Geneva, Switzerland) female‐to‐male 100 implant (ZSI FtM 100) specifically for phalloplasty ...
Maya Levy   +5 more
wiley   +1 more source

The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection

open access: yesBJU International, EarlyView.
Background Penile cancer is a rare malignancy, with an Australian incidence of 0.6 in 100 000 men, with a wide range of clinical presentations, from localised, curable tumours to aggressive forms with high morbidity and mortality. Epidemiological data and management guidelines for penile cancer in Australia are limited.
Henry Y.C. Pan   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy